Enhancement techniques for improving 5-aminolevulinic acid delivery through the skin

Dermatologica Sinica

Volumn 29, Issue 1, 2011, Pages 1-7

  Zhang, Li Wen ^a   Fang, Yi Ping ^b   Fang, Jia You ^a,c,d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

5 Aminolevulinic acid (ALA); Enhancers; Penetration; Photodynamic therapy; Transdermal drug delivery

Indexed keywords

6 OXOCHOLESTANOL; AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE; EDETIC ACID; LIPOSOME; OLEIC ACID; PHLORETIN;

ARTICLE; DRUG DELIVERY SYSTEM; IONTOPHORESIS; LASER; NEEDLE; NONHUMAN; PHOTODYNAMIC THERAPY; SKIN PENETRATION; TECHNIQUE; ULTRASOUND;

EID: 79954424349     PISSN: 10278117     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsi.2011.02.002     Document Type: Review

References (59)

1. R.F.V. Lopez, N. Lange, and R. Guy Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters Adv Drug Deliv Rev 56 2004 77 94 (Pubitemid 38045425)
2. F. De Rosa, and M.V. Bentley Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives Pharm Res 17 2000 1447 1455 (Pubitemid 32218725)
3. A. Casas, H. Fukuda, and R. Meiss Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma Cancer Lett 141 1999 29 38 (Pubitemid 29261718)
4. T.J. Dougherty, G.B. Grindey, and R. Fiel Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light J Natl Cancer Inst 55 1975 115 121
5. C.H. Sibata, V.C. Colussi, and N.L. Oleinick Photodynamic therapy in oncology Expert Opin Pharmacother 2 2001 917 927 (Pubitemid 32750348)
6. S. Sil, T. Bose, and D. Roy Protoporphyrin IX-induced structural and functional changes in human red blood cells, haemoglobin and myoglobin J Biosci 29 2004 281 291 (Pubitemid 39279204)
7. J.Y. Fang, and Y.L. Leu Prodrug strategy for enhancing drug delivery via skin Curr Drug Discov Technol 3 2006 211 224
8. H.A. Benson Transdermal drug delivery: penetration enhancement techniques Curr Drug Deliv 2 2005 23 33 (Pubitemid 40590918)
9. I.B. Pathan, and C.M. Setty Chemical penetration enhancers for transdermal drug delivery systems Trop J Pharm Res 8 2009 173 179
10. N. He, K.S. Warner, and D. Chantasart Mechanistic study of chemical skin permeation enhancers with different polar and lipophilic functional groups J Pharm Sci 93 2004 1415 1430 (Pubitemid 38725016)
11. M.A. Kamal, T. Nabekura, and S. Kitagawa Permeability of ionized salicylate derivatives through guinea pig dorsal skin Chem Pharm Bull (Tokyo) 53 2005 441 443 (Pubitemid 40879888)
12. L.D. Simonetti, G.M. Gelfuso, and J.C. Barbosa Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway Eur J Pharm Biopharm 73 2009 90 94
13. A. Davidson, B. Al-Qallaf, and D.B. Das Transdermal drug delivery by coated microneedles: geometry effects on effective skin thickness and drug permeability AIChE J 86 2008 1196 1206
14. S. Scheindlin Transdermal drug delivery: past, present, future Mol Interv 4 2004 308 312 (Pubitemid 40124375)
15. T. Tanner, and R. Marks Delivering drugs by the transdermal route: review and comment Skin Res Technol 14 2008 249 260
16. B.C. Finnin, and T.M. Morgan Transdermal penetration enhancers: applications, limitations, and potential J Pharm Sci 88 1999 955 958 (Pubitemid 29480582)
17. B. Godin, and E. Touitou Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models Adv Drug Deliv Rev 59 2007 1152 1161 (Pubitemid 47615204)
18. S.S. Lanke, C.S. Kolli, and J.G. Strom Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation Int J Pharm 365 2009 26 33
19. J.C. Kennedy, R.H. Pottier, and D.C. Pross Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience J Photochem Photobiol B 6 1990 143 148
20. A.T. Dijkstra, I.M. Majoie, and J.W. van Dongen Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma J Eur Acad Dermatol Venereol 15 2001 550 554 (Pubitemid 34041188)
21. N.C. Zeitouni, A.R. Oseroff, and S. Shieh Photodynamic therapy for nonmelanoma skin cancers. Current review and update Mol Immunol 39 2003 1133 1136 (Pubitemid 36776569)
22. J.A. Leman, D.C. Dick, and C.A. Morton Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma Clin Exp Dermatol 27 2002 516 518 (Pubitemid 35278948)
23. F.S. De Rosa, J.M. Marchetti, and J.A. Thomazini A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy J Control Release 65 2000 359 366 (Pubitemid 30122938)
24. W.R. Lee, S.C. Shen, and M.H. Pai Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser J Control Release 145 2010 124 133
25. R.F. Donnelly, P.A. McCarron, and A.D. Woolfson Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy Photochem Photobiol 81 2005 750 767 (Pubitemid 41265037)
26. S.R. Wiegell, I.M. Stender, and R. Na Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin Arch Dermatol 139 2003 1173 1177 (Pubitemid 37128379)
27. G. Di Venosa, L. Hermida, and H. Fukuda Comparation of liposomal formulations of ALA undecanoyl ester for its use in photodynamic therapy J Photochem Photobiol B 96 2009 152 158
28. D.I. Morrow, P.A. McCarron, and A.D. Woolfson Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses J Pharm Sci 99 2010 3486 3498
29. J.T. van den Akker, V. Iani, and W.M. Star Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum Photochem Photobiol 72 2000 681 689
30. J.M. Gaullier, K. Berg, and Q. Peng Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture Cancer Res 57 1997 1481 1486 (Pubitemid 27175564)
31. F.S. De Rosa, A.C. Tedesco, and R.F. Lopez In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy J Control Release 89 2003 261 269 (Pubitemid 36507020)
32. A. Juzeniene, P. Juzenas, and L.W. Ma Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin Br J Dermatol 155 2006 791 799 (Pubitemid 44352561)
33. R.F. Lopez, M.V. Bentley, and M. Begona Delgado-Charro Optimization of aminolevulinic acid delivery by iontophoresis J Control Release 88 2003 65 70 (Pubitemid 36173952)
34. R.F. Lopez, M.V. Bentley, and M.B. Delgado-Charro Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro Photochem Photobiol 77 2003 304 308
35. S.C. Shen, W.R. Lee, and Y.P. Fang In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser J Pharm Sci 95 2006 929 938
36. R.F. Donnelly, D.I. Morrow, and P.A. McCarron Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy J Control Release 129 2008 154 162
37. P. Mikolajewska, R.F. Donnelly, and M.J. Garland Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema Pharm Res 27 2010 2213 2220
38. L. Ma, J. Moan, and Q. Peng Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound Int J Cancer 78 1998 464 469 (Pubitemid 28481165)
39. R.H. Guy Transdermal drug delivery Handb Exp Pharmacol 197 2010 399 410
40. R.F. Lopez, M.V. Bentley, and M.B. Delgado-Charro Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH Pharm Res 18 2001 311 315 (Pubitemid 32595818)
41. G.W. Cleary Microneedles for drug delivery Pharm Res 28 2010 1 6
42. R.F. Donnelly, T.R.R. Singh, and A.D. Woolfson Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety Drug Deliv 17 2010 187 207
43. J.H. Park, S.O. Choi, and S. Seo A microneedle roller for transdermal drug delivery Eur J Pharm Biopharm 76 2010 282 289
44. W.L. Nyborg Ultrasonic microstreaming and related phenomena Br J Cancer Suppl 5 1982 156 160 (Pubitemid 12075925)
45. A.C. Williams, and B.W. Barry Penetration enhancers Adv Drug Deliv Rev 56 2004 603 618 (Pubitemid 38326936)
46. Z. Malik, G. Kostenich, and L. Roitman Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice J Photochem Photobiol B 28 1995 213 218
47. M.B. Pierre, E. Ricci Jr., and A.C. Tedesco Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy Pharm Res 23 2006 360 366 (Pubitemid 43237865)
48. A. Bunke, O. Zerbe, and H. Schmid Degradation mechanism and stability of 5-aminolevulinic acid J Pharm Sci 89 2000 1335 1341
49. J.Y. Fang, P.C. Wu, and C.L. Fang Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems J Pharm Sci 99 2010 2375 2385
50. J.Y. Fang, C.T. Hong, and W.T. Chiu Effect of liposomes and niosomes on skin permeation of enoxacin Int J Pharm 219 2001 61 72
51. A. Casas, H. Fukuda, and A.M. Batlle Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles Br J Cancer 81 1999 13 18 (Pubitemid 29415485)
52. A. Casas, H. Fukuda, and G. Di Venosa The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization Br J Dermatol 143 2000 564 572
53. C. Valenta, B.G. Auner, and I. Loibl Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation J Control Release 107 2005 495 501 (Pubitemid 41398070)
54. D. Zucker, D. Marcus, and Y. Barenholz Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties J Control Release 139 2009 73 80
55. J.Y. Fang Nano- or submicron-sized liposomes as carriers for drug delivery Chang Gung Med J 29 2006 358 362
56. H.C. Korting, and M. Schafer-Korting Carriers in the topical treatment of skin disease Handb Exp Pharmacol 197 2010 435 468
57. M.B. Pierre, A.C. Tedesco, and J.M. Marchetti Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study BMC Dermatol 1 2001 5
58. B.G. Auner, C. Valenta, and J. Hadgraft Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid Int J Pharm 255 2003 109 116 (Pubitemid 36369595)
59. L.M. Araujo, J.A. Thomazine, and R.F. Lopez Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy Eur J Pharm Biopharm 75 2010 48 55